[1]Tani,Masanobu;Ariyasu,Takahiro;Ohtsuka,Masanori;Koga,Terumi;Ogawa,Yumi;Yokoyama,Yuusaku;Murakami,Yasuoki[ChemicalandPharmaceuticalBulletin,1996,vol.44,#1,p.55-61]
119647-73-3
1421601-27-5
1979149-35-3
174794-02-6 | 10H-Thieno[2,3-b][1,5]benzodiazepine, 2-methyl-4-(4-methyl-4-oxido-1-piperazinyl)- | AA001ZV6 | MFCD08703077
175135-62-3 | 2-(2,4-Difluorophenoxy)-3-nitropyridine | AA00204Q | MFCD00067800
175143-93-8 | 3-(2-Fluorophenyl)propionaldehyde | AA0020AE | MFCD09028588
175204-85-0 | 4-(Trifluoromethyl)pyridine-3-carboxamide oxime | AA0020JT | MFCD00219948
175278-14-5 | 4-Bromo-2-(trifluoromethoxy)benzene-1-sulfonyl chloride | AA0020QP | MFCD00179336
17557-67-4 | 2-Amino-6-(methylsulfonyl)benzothiazole | AA0020ZC | MFCD00179133
17605-67-3 | Stigmasta-5,24(28)-dien-3-ol, (3β,24E)- | AA0021BN | MFCD00037543
180182-07-4 | Piperidin-4-yl-acetic acid tert-butyl ester | AA0021P3 | MFCD06738957
1805-67-0 | 5-Methylisophthalaldehyde | AA0021Z4 | MFCD00182499
1808091-49-7 | 2,6-Diaminophenol hydrochloride | AA0022AF | MFCD29037383